Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other Non-Current Assets (2017 - 2020)

Sunshine Biopharma's Other Non-Current Assets history spans 4 years, with the latest figure at $7590.0 for Q4 2020.

  • For Q4 2020, Other Non-Current Assets changed N/A year-over-year to $7590.0; the TTM value through Dec 2020 reached $7590.0, changed N/A, while the annual FY2020 figure was $7590.0, N/A changed from the prior year.
  • Other Non-Current Assets reached $7590.0 in Q4 2020 per SBFM's latest filing, down from $989572.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $989572.0 in Q4 2018 to a low of $7590.0 in Q4 2020.
  • Average Other Non-Current Assets over 4 years is $510725.3, with a median of $534931.0 recorded in 2017.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 1132.5% in 2018, then skyrocketed 12658.79% in 2019.
  • A 4-year view of Other Non-Current Assets shows it stood at $80290.0 in 2017, then surged by 1132.5% to $989572.0 in 2018, then changed by 0.0% to $989572.0 in 2019, then plummeted by 99.23% to $7590.0 in 2020.
  • Per Business Quant, the three most recent readings for SBFM's Other Non-Current Assets are $7590.0 (Q4 2020), $989572.0 (Q2 2019), and $989572.0 (Q1 2019).